BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 14510086)

  • 1. Advances in management of sickle cell disease.
    Agarwal MB
    Indian J Pediatr; 2003 Aug; 70(8):649-54. PubMed ID: 14510086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initiating adjunct low-dose hydroxyurea therapy for stroke prevention in children with SCA during the COVID-19 pandemic.
    DeBaun MR
    Blood; 2020 May; 135(22):1997-1999. PubMed ID: 32282033
    [No Abstract]   [Full Text] [Related]  

  • 3. Principles and indications of chronic transfusion therapy for children with sickle cell disease.
    Ware R
    Clin Adv Hematol Oncol; 2007 Sep; 5(9):686-8. PubMed ID: 17982409
    [No Abstract]   [Full Text] [Related]  

  • 4. Prospects for primary stroke prevention in children with sickle cell anaemia.
    Jordan LC; Casella JF; DeBaun MR
    Br J Haematol; 2012 Apr; 157(1):14-25. PubMed ID: 22224940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurologic and Cognitive Outcomes in Sickle Cell Disease from Infancy through Adolescence.
    Mayer SL; Fields ME; Hulbert ML
    Neoreviews; 2021 Aug; 22(8):e531-e539. PubMed ID: 34341160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of sickle cell disease from a life-threatening disease of children to a chronic disease of adults: The last 40 years.
    Chaturvedi S; DeBaun MR
    Am J Hematol; 2016 Jan; 91(1):5-14. PubMed ID: 26547630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current and emerging treatments for sickle cell disease.
    Monus T; Howell CM
    JAAPA; 2019 Sep; 32(9):1-5. PubMed ID: 31460979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expanding the role of hydroxyurea in children with sickle cell disease.
    Rogers ZR; Buchanan GR
    J Pediatr; 2004 Sep; 145(3):287-8. PubMed ID: 15343174
    [No Abstract]   [Full Text] [Related]  

  • 9. Approximately 40 000 children with sickle cell anemia require screening with TCD and treating with hydroxyurea for stroke prevention in three states in northern Nigeria.
    Galadanci AA; Galadanci NA; Jibir BW; Abdullahi SU; Idris N; Gambo S; Ali Abubakar SA; Kabo NA; Bello-Manga H; Haliru L; Bashir I; Aliyu MH; Galadanci JA; DeBaun MR
    Am J Hematol; 2019 Nov; 94(11):E305-E307. PubMed ID: 31423630
    [No Abstract]   [Full Text] [Related]  

  • 10. Sickle cell disease.
    Ware RE; de Montalembert M; Tshilolo L; Abboud MR
    Lancet; 2017 Jul; 390(10091):311-323. PubMed ID: 28159390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sickle cell disease in North Europe.
    Howard J; Davies SC
    Scand J Clin Lab Invest; 2007; 67(1):27-38. PubMed ID: 17365983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sickle cell disease--pathophysiology and treatment.
    Redding-Lallinger R; Knoll C
    Curr Probl Pediatr Adolesc Health Care; 2006; 36(10):346-76. PubMed ID: 17055417
    [No Abstract]   [Full Text] [Related]  

  • 13. Sickle cell disease.
    Fixler J; Styles L
    Pediatr Clin North Am; 2002 Dec; 49(6):1193-210, vi. PubMed ID: 12580362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The case for and against initiating either hydroxyurea therapy, blood transfusion therapy or hematopoietic stem cell transplant in asymptomatic children with sickle cell disease.
    Kassim AA; DeBaun MR
    Expert Opin Pharmacother; 2014 Feb; 15(3):325-36. PubMed ID: 24392871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxyurea as secondary prevention for stroke in children with sickle cell anemia.
    DeBaun MR
    J Pediatr; 2005 Oct; 147(4):560-1. PubMed ID: 16227052
    [No Abstract]   [Full Text] [Related]  

  • 16. Sickle cell anaemia: current therapies.
    Vermylen C
    Transfus Apher Sci; 2013 Oct; 49(2):151-4. PubMed ID: 23954416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute complications of sickle cell disease in children.
    Drug Ther Bull; 2001 May; 39(5):33-7. PubMed ID: 11396389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sickle Cell Disease: Monitoring, Current Treatment, and Therapeutics Under Development.
    Hoppe C; Neumayr L
    Hematol Oncol Clin North Am; 2019 Jun; 33(3):355-371. PubMed ID: 31030807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sickle cell disease: new insights into pathophysiology and treatment.
    Inati A; Koussa S; Taher A; Perrine S
    Pediatr Ann; 2008 May; 37(5):311-21. PubMed ID: 18543542
    [No Abstract]   [Full Text] [Related]  

  • 20. Sickle cell disease.
    McCavit TL
    Pediatr Rev; 2012 May; 33(5):195-204; quiz 205-6. PubMed ID: 22550263
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.